ARTICLE | Company News
IntelGenx, RedHill deal
September 6, 2010 7:00 AM UTC
RedHill received exclusive, worldwide rights to co-develop and market IntelGenx's anti-migraine oral film product. The serotonin (5-HT) receptor antagonist, which is delivered by IntelGenx's VersaFilm oral disintegrating film, has completed a Phase I trial. ...